SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 17 Jun 2022
Last Applicant/ Owned by
J.H. Oortweg 19
Leiden
NL
2333CH
Serial Number
86288618 filed on 22nd May 2014
Registration Number
4767213 registered on 07th Jul 2015
Correspondent Address
Peter Nussbaum
Filing Basis
1. intent to use
Disclaimer
NO DATA
ISA PHARMACEUTICALS
Scientific and technological services and research and design relating thereto in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy; industrial analysis, namely, analysis of the design, manufacturing and development of immunotherapy pharmaceuticals; research services in the field of pharmaceuticals; scientific research and development services in the biotech Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services in the biotechnological and pharmaceutical field and in the field of immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services and research and design relating thereto in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy; industrial analysis, namely, analysis of the design, manufacturing and development of immunotherapy pharmaceuticals; research services in the field of pharmaceuticals; scientific research and development services in the biotechnological, chemical and pharmaceutical field and in the field of immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
[ Pharmaceutical and medicinal preparations for the treatment of viral infections, cancer and pre-cancerous disorders; active pharmaceutical substances based on synthetic long peptides which may be modified to improve the immune response and may be combined with other pharmaceutical products for the treatment of viral infections, cancer and pre-cancerous disorders; immune response adjuvants for medical purposes; pharmaceutical compounds for treating viral infections, cancer and pre-cancerous disorders by means of immune system modulation ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 86288618
Mark Type
No Service Mark
Attorney Docket Number
No 16447/1/2
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Jul 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 26th Jan 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 26th Jan 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 26th Jan 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Jun 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 17th Jun 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 17th Jun 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 07th Jan 2022 | TEAS SECTION 8 & 15 RECEIVED |
| 07th Jul 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 07th Jul 2015 | REGISTERED-PRINCIPAL REGISTER |